(Reuters) — AquaBounty Technologies’ salmon has become the first genetically modified animal to receive U.S. approval for human consumption, setting the stage for more such approvals.
The approval comes with the condition that the salmon be raised only in two specific land-based, contained hatchery tanks in Canada and Panama, and not in the United States.
The U.S. Food and Drug Administration said the company’s GM Atlantic salmon was as nutritious as the farm-raised ones and was safe for consumption.
“AquaBounty developed a form of salmon that grows faster and is much more efficient in the conversion of feed to protein, compared to conventional salmon,” said University of Edinburgh professor Helen Sang.